US Patent 8148371 Adenine compound and use thereof
Patent 8148371 was granted and assigned to Dainippon Sumitomo on April, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+226 characters)
Article
Patent abstract
A drug for topically administration which is effective as an antiallergic agent. The drug for topically administration contains as an active ingredient an adenine compound represented by the general formula (1):
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08148371 Adenine compound and use thereof US Patent 8148371 Adenine compound and use thereof
Infobox
Patent Number
0814837100
Patent Number
814837100
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081483710
Date of Patent
April 3, 2012
0Patent Application Number
127936490
Date Filed
June 3, 2010
0Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081483710
Date of Patent
April 3, 2012
0Patent Application Number
127936490
Date Filed
June 3, 2010
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08148371 Adenine compound and use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08148371
Date of patent
April 3, 2012
Patent application number
12793649
Date Filed
June 3, 2010
Patent primary examiner
Find more entities like US Patent 8148371 Adenine compound and use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
